Espumisan® L (Emulsion) Instructions for Use
Marketing Authorization Holder
Berlin-Chemie/Menarini Pharma, GmbH (Germany)
Manufactured By
Berlin-Chemie, AG (Germany)
ATC Code
A03AX13 (Silicones)
Active Substance
Simeticone (Rec.INN registered by WHO)
Dosage Form
| Espumisan® L | Oral emulsion 40 mg/1 ml: 30 ml bottle with dropper cap and measuring cap |
Dosage Form, Packaging, and Composition
Oral emulsion milky-white in color, slightly viscous, with a banana odor.
| 1 ml (25 drops) | |
| Simeticone | 40 mg |
Excipients: hypromellose (M.W.=3.0), sorbic acid, sodium cyclamate, sodium saccharin, banana flavor No.516060, purified water.
30 ml – dark glass bottles with a dropper cap (1) – cardboard boxes.
Clinical-Pharmacological Group
A drug reducing flatulence
Pharmacotherapeutic Group
Carminative agent
Pharmacological Action
The active component Simeticone is a surfactant that reduces the surface tension of gas bubbles in the gastrointestinal tract, causing them to break down.
The use of simeticone for the preparation and performance of diagnostic procedures prevents the occurrence of image defects caused by gas bubbles.
Pharmacokinetics
Simeticone is not absorbed from the gastrointestinal tract. It is excreted from the body unchanged.
Indications
- Symptoms of flatulence: bloating, feeling of pressure and fullness in the epigastric region, increased gas formation (including in the postoperative period, as well as in newborns and infants);
- Intestinal colic;
- Preparation for diagnostic examinations of the abdominal and pelvic organs (ultrasound, radiography), including as an additive to contrast agent suspensions for double-contrast imaging;
- Poisoning by detergents (including surfactants contained in detergents) as a defoaming agent.
ICD codes
| ICD-10 code | Indication |
| K30 | Functional dyspepsia (digestive disorder) |
| P78.9 | Disorder of the digestive system in the perinatal period, unspecified |
| R10.4 | Other and unspecified abdominal pain (colic) |
| R14 | Flatulence and related conditions (including abdominal bloating, belching) |
| T55 | Toxic effect of soaps and detergents |
| Z51.4 | Preparatory procedures for subsequent treatment or examination, not elsewhere classified |
| ICD-11 code | Indication |
| DD90.0 | Globus sensation |
| DD90.1 | Functional dysphagia |
| DD90.3 | Functional dyspepsia |
| DD90.Z | Functional disorders of esophagus or gastroduodenal system, unspecified |
| DD93.1 | Infantile colic |
| KB80 | Gastro-esophageal reflux disease in newborns |
| KB81.0 | Eosinophilic esophagitis in newborns |
| KB8Z | Digestive system disorders of fetus or newborn, unspecified |
| MD81.4 | Other and unspecified abdominal pain |
| ME08 | Flatulence and related conditions |
| NE61 | Toxic effect of poisonous substances, chiefly nonmedicinal, not elsewhere classified |
| QB9A | Preparatory procedures for subsequent treatment |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
The drug is taken orally during or after meals, and if necessary also before bedtime.
For flatulence, adults and children over 14 years of age are prescribed 2 ml (50 drops) of emulsion 3-5 times/day; children aged 6 to 14 years – 1-2 ml (25-50 drops) 3-5 times/day; children aged 1 to 6 years – 1 ml (25 drops) 3-5 times/day; infants – 1 ml (25 drops) of the drug is added to a bottle with baby food or given with a small spoon before or after breastfeeding.
The duration of use depends on the severity of symptoms. If necessary, the drug can be taken for a long time.
For preparation for radiography and ultrasound examination of the abdominal organs, 2 ml (50 drops) are prescribed 3 times/day the day before the examination and 2 ml (50 drops) in the morning on the day of the examination.
For obtaining a double-contrast image, add 4-8 ml (100-200 drops) of emulsion per 1 liter of contrast suspension.
For poisoning by detergents, the drug is prescribed to adults 10-20 ml (1/3-2/3 of the bottle contents), children – 2.5-10 ml (65 drops – 1/3 of the bottle contents) of the drug depending on the severity of poisoning.
Adverse Reactions
No adverse reactions associated with the use of the drug have been observed.
Contraindications
- Intestinal obstruction;
- Hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
Data on the possibility and safety of using the drug during pregnancy and lactation have not been provided.
Pediatric Use
Used in children according to indications in accordance with the dosage regimen.
Special Precautions
The drug can also be taken after surgeries.
The emulsion does not contain sugar and can be used in patients with diabetes mellitus.
Drug Interactions
No clinically significant interaction of the drug with other medicinal products has been established.
Storage Conditions
Store at 2°C (36°F) to 30°C (86°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer